CG

Chandrakant Govindbhai Parmar

Active Director Whole-Time Director DIN 09406801
DIN 09406801 First appointment Nov 2021 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Nov 2021
Shareholding value •••• Premium profile

About Chandrakant Govindbhai Parmar

Data last updated:

Chandrakant Govindbhai Parmar is a Whole-Time Director at Regis Industries Limited (since 2021), Additional Director at Malabar Trading Company Limited (since 2021) and Director at Biogen Pharmachem Industries Limited (since 2021). The companies operate in Financial Services and Agriculture. The 3 current companies with reported revenue have a combined latest revenue of ₹23.70 Cr; the largest is Regis Industries Limited at ₹16.70 Cr (FY 2025). Earlier, Chandrakant Govindbhai Parmar was an Additional Director at Interface Financial Services Ltd (2021–2025).

DIN 09406801
Primary Designation Whole-Time Director
Industry Financial Services
First Appointment 22 Nov 2021
Oldest Company Age 46 yrs
Largest company Regis Industries Limited · ₹16.70 Cr (FY 2025)
Combined revenue ₹23.70 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regis Industries Limited L51109WB1982PLC034759
Whole-Time Director22 Nov 20211982₹16.70 Cr (FY 2025)Active
Malabar Trading Company Limited L51900GJ1980PLC092150
Additional Director22 Nov 20211980₹5.80 Cr (FY 2025)Active
Biogen Pharmachem Industries Limited L51100GJ1995PLC026702
Director22 Nov 20211995₹1.20 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Interface Financial Services Ltd L74910GJ1992PLC016866
Additional Director22 Nov 20211992₹6.30 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Biogen Pharmachem Industries Limited
Regis Industries Limited
Malabar Trading Company Limited
Interface Financial Services Ltd
Premium access

Shareholding and investment profile for Chandrakant Govindbhai Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandrakant Govindbhai Parmar

Chandrakant Govindbhai Parmar currently holds 3 directorships: Regis Industries Limited (Whole-Time Director, since 22 Nov 2021, revenue ₹16.70 Cr (FY 2025)); Malabar Trading Company Limited (Additional Director, since 22 Nov 2021, revenue ₹5.80 Cr (FY 2025)); Biogen Pharmachem Industries Limited (Director, since 22 Nov 2021, revenue ₹1.20 Cr (FY 2025)).

Chandrakant Govindbhai Parmar was first appointed on 22 Nov 2021 as Whole-Time Director at Regis Industries Limited.

The 3 current companies of Chandrakant Govindbhai Parmar that report revenue have a combined latest revenue of ₹23.70 Cr: Regis Industries Limited ₹16.70 Cr (FY 2025); Malabar Trading Company Limited ₹5.80 Cr (FY 2025); Biogen Pharmachem Industries Limited ₹1.20 Cr (FY 2025).

Chandrakant Govindbhai Parmar held 1 earlier board appointment: Interface Financial Services Ltd (Additional Director, 22 Nov 2021 to 24 Feb 2025).

The current boards of Chandrakant Govindbhai Parmar's companies include Aman Pravinkumar Patel (Regis Industries Limited), Chhayaben Maheshbhai Parmar (Regis Industries Limited), Kelash Bunkar (Regis Industries Limited), Kinjal Pankajbhai Dalal (Regis Industries Limited), Manish Prajapat (Regis Industries Limited), Manish Prajapat (Regis Industries Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available